147 related articles for article (PubMed ID: 24070777)
21. Melanin protects melanocytes and keratinocytes against H2O2-induced DNA strand breaks through its ability to bind Ca2+.
Hoogduijn MJ; Cemeli E; Ross K; Anderson D; Thody AJ; Wood JM
Exp Cell Res; 2004 Mar; 294(1):60-7. PubMed ID: 14980501
[TBL] [Abstract][Full Text] [Related]
22. Poly(adp-ribose) polymerase inhibitors: a novel drug class with a promising future.
Gartner EM; Burger AM; Lorusso PM
Cancer J; 2010; 16(2):83-90. PubMed ID: 20404603
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.
Venere M; Hamerlik P; Wu Q; Rasmussen RD; Song LA; Vasanji A; Tenley N; Flavahan WA; Hjelmeland AB; Bartek J; Rich JN
Cell Death Differ; 2014 Feb; 21(2):258-69. PubMed ID: 24121277
[TBL] [Abstract][Full Text] [Related]
24. A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity.
Pettitt SJ; Rehman FL; Bajrami I; Brough R; Wallberg F; Kozarewa I; Fenwick K; Assiotis I; Chen L; Campbell J; Lord CJ; Ashworth A
PLoS One; 2013; 8(4):e61520. PubMed ID: 23634208
[TBL] [Abstract][Full Text] [Related]
25. Stratifying prostate patients for olaparib.
Cancer Discov; 2015 Jun; 5(6):568-9. PubMed ID: 25904654
[TBL] [Abstract][Full Text] [Related]
26. Nitrofuran induced mutagenesis and error prone repair in Escherichia coli.
Bryant DW; McCalla DR
Chem Biol Interact; 1980 Aug; 31(2):151-66. PubMed ID: 6993027
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma.
George SL; Lorenzi F; King D; Hartlieb S; Campbell J; Pemberton H; Toprak UH; Barker K; Tall J; da Costa BM; van den Boogaard ML; Dolman MEM; Molenaar JJ; Bryant HE; Westermann F; Lord CJ; Chesler L
EBioMedicine; 2020 Sep; 59():102971. PubMed ID: 32846370
[TBL] [Abstract][Full Text] [Related]
28. Olaparib Targets Some Advanced Prostate Cancers.
Cancer Discov; 2016 Jan; 6(1):OF1. PubMed ID: 26658963
[TBL] [Abstract][Full Text] [Related]
29. Investigating the role of melanin in UVA/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells.
Swalwell H; Latimer J; Haywood RM; Birch-Machin MA
Free Radic Biol Med; 2012 Feb; 52(3):626-634. PubMed ID: 22178978
[TBL] [Abstract][Full Text] [Related]
30. The DNA-damage response: new molecular insights and new approaches to cancer therapy.
Jackson SP
Biochem Soc Trans; 2009 Jun; 37(Pt 3):483-94. PubMed ID: 19442242
[TBL] [Abstract][Full Text] [Related]
31. The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells.
Kvam E; Tyrrell RM
J Invest Dermatol; 1999 Aug; 113(2):209-13. PubMed ID: 10469305
[TBL] [Abstract][Full Text] [Related]
32. Novel therapeutic compound acridine-retrotuftsin action on biological forms of melanoma and neuroblastoma.
Cichorek M; Ronowska A; Gensicka-Kowalewska M; Deptula M; Pelikant-Malecka I; Dzierzbicka K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):165-179. PubMed ID: 30367436
[TBL] [Abstract][Full Text] [Related]
33. Nitrofuran drugs beyond redox cycling: Evidence of Nitroreduction-independent cytotoxicity mechanism.
Gallardo-Garrido C; Cho Y; Cortés-Rios J; Vasquez D; Pessoa-Mahana CD; Araya-Maturana R; Pessoa-Mahana H; Faundez M
Toxicol Appl Pharmacol; 2020 Aug; 401():115104. PubMed ID: 32531296
[TBL] [Abstract][Full Text] [Related]
34. Eumelanin causes DNA strand breaks and kills cells.
Hill HZ; Hill GJ
Pigment Cell Res; 1987; 1(3):163-70. PubMed ID: 3508274
[TBL] [Abstract][Full Text] [Related]
35. Action of nitrofurans on E. coli: mutation and induction and repair of daughter-strand gaps in DNA.
Lu C; McCalla DR; Bryant DW
Mutat Res; 1979 Jun; 67(2):133-44. PubMed ID: 381913
[TBL] [Abstract][Full Text] [Related]
36. Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability.
Farmer PJ; Gidanian S; Shahandeh B; Di Bilio AJ; Tohidian N; Meyskens FL
Pigment Cell Res; 2003 Jun; 16(3):273-9. PubMed ID: 12753401
[TBL] [Abstract][Full Text] [Related]
37. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.
Aziz K; Nowsheen S; Georgakilas AG
Curr Mol Med; 2010 Oct; 10(7):626-39. PubMed ID: 20712589
[TBL] [Abstract][Full Text] [Related]
38. Mutagenicity of nifurtimox in Escherichia coli.
Ohnishi T; Ohashi Y; Nozu K; Inoki S
Mutat Res; 1980 Mar; 77(3):241-4. PubMed ID: 6991921
[TBL] [Abstract][Full Text] [Related]
39. Circumventing melanoma chemoresistance by targeting DNA repair.
Mocellin S; Bertazza L; Benna C; Pilati P
Curr Med Chem; 2012; 19(23):3893-9. PubMed ID: 22788765
[TBL] [Abstract][Full Text] [Related]
40. Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines?
Hill HZ; Cathcart KN; Bargellini J; Trizna Z; Hill GJ; Schallreuter KU; Wood JM
Pigment Cell Res; 1991 Mar; 4(2):80-6. PubMed ID: 1946213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
